{"id":"W3171070684","doi":"10.1200/jco.2021.39.15_suppl.9024","title":"A phase II study of rucaparib in patients with high genomic LOH and/or BRCA 1/2 mutated stage IV non-small cell lung cancer (Lung-MAP Sub-Study, S1900A).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institutes of Health","keywords":"Medicine; Internal medicine; Oncology; Cohort; Lung cancer; Cancer; Interim analysis; Stage (stratigraphy); PARP inhibitor; Clinical trial; Genetics; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002074546,0.00155777,0.00175872,0.0003706488,0.0003870804,0.0009146948,0.0009108568,0.001247443,0.005726309],"category_scores_gemma":[0.001110491,0.0006778312,0.001558238,0.0003926533,0.0006999523,0.0007553714,0.0004657522,0.002707352,0.001548622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007962795,"about_ca_system_score_gemma":0.00151113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00111589,"about_ca_topic_score_gemma":0.002744615,"domain_scores_codex":[0.9994634,0.0003060508,0.00002080655,0.00007943052,0.00003618145,0.00009409301],"domain_scores_gemma":[0.9991215,0.0001439734,0.0001401402,0.00008645701,0.00006554453,0.0004424355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8379657,0.05922638,0.01071303,0.0009294661,0.001744285,0.0003720434,0.0002815448,0.001752424,0.02418571,0.0003716158,0.007119178,0.05533873],"study_design_scores_gemma":[0.636752,0.343519,0.0125452,0.00003347491,0.0006216878,0.0003048822,0.00008365444,0.0008062359,0.001476831,0.0003077333,0.003528289,0.00002107569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789734,0.003125458,0.001186807,0.000770072,0.0002629355,0.008447023,0.003641666,0.000144548,0.00344812],"genre_scores_gemma":[0.9752984,0.002230637,0.002188222,0.001580157,0.0002719921,0.00765208,0.006143048,0.00005331345,0.004582078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005726309,"threshold_uncertainty_score":0.0191564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05890934860739652,"score_gpt":0.4388653226790993,"score_spread":0.3799559740717028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}